出版物 打印 Grach SL, Dudenkov DV, Pollack B, Fairweather D, Aakre CA, Munipalli B, Croghan IT, Mueller MR, Overgaard JD, Bruno KA, Collins NM, Li Z, Hurt RT, Tal MC, Ganesh R, Knight DTR. Overlapping conditions in Long COVID at a multisite academic center. Front Neurol. 2024; 15:1482917 Epub 2024 Oct 25 View PubMed Smith SJ, Smith BH, Sichlau MJ, Chen B, Knight D, Rowe PC. Nonpelvic comorbid symptoms of 45 patients with pain of pelvic venous origin, before and after treatment. Phlebology. 2024 Aug 10; 2683555241273109 [Epub ahead of print] View PubMed Old EA, Gajarawala S, Knight DR, Pak K, Carrubba AR. Successful Removal of Six Levonorgestrel Silastic Subcutaneous Implants (Norplant) 25 Years After Insertion: A Case Report. Cureus. 2024 Jul; 16 (7):e63585 Epub 2024 July 01 View PubMed Harris Cheryl, Knight D, Mejia Lisa, Bilyeu Laurie. Nutritional Considerations for Hypermobile Ehlers-Danlos Syndrome Practical Gastroenterology. 2024; (Series #13). Smith SJ, Sichlau MJ, Smith BH, Knight DR, Chen B, Rowe PC. Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency. Phlebology. 2024 Apr; 39 (3):202-213 Epub 2023 Dec 05 View PubMed Wagner W, Doyle TA, Francomano CA, Knight DRT, Halverson CME. Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region. Orphanet J Rare Dis. 2024 Mar 14; 19 (1):122 View PubMed Menton SM, Fairweather D, Bruno KA, Thompson CC, Candelo E, Darakjian AA, Gehin JM, Jain A, Kotha A, Whelan ER, Li Z, Knight DRT, Rutt AL. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders. Laryngoscope. 2024 Feb; 134 (2):773-778 Epub 2023 Aug 19 View PubMed Knight DRT, Bruno KA, Singh A, Munipalli B, Gajarawala S, Solomon M, Kocsis SC, Darakjian AA, Jain A, Whelan ER, Kotha A, Gorelov DJ, Phillips SD, Fairweather D. Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study. Front Cardiovasc Med. 2024; 11:1332508 Epub 2024 Mar 18 View PubMed Schubart JR, Schaefer EW, Knight DRT, Mills SE, Francomano CA. Estimates of the excess cost burden of Ehlers-Danlos syndromes: a United States MarketScan(R) claims database analysis. Front Public Health. 2024; 12:1365712 Epub 2024 July 03 View PubMed Darakjian AA, Bhutani M, Fairweather D, Kocsis SC, Fliess JJ, Khatib S, Weigel GJ, McCabe EJ, Balamurugan V, Perona EE, Gehin JM, Whelan ER, Jain A, Sledge H, Hodge DO, Rozen TD, Farraye FA, Soyer O, Cheung J, Grach SL, Shirey D Jr, Gajarawala S, Munipalli B, Shufelt CL, Knight DRT, Bruno KA. Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Rheumatol Adv Pract. 2024; 8 (4):rkae134 Epub 2024 Nov 04 View PubMed Knight DR, Aakre CA, Anstine CV, Munipalli B, Biazar P, Mitri G, Valery JR, Brigham T, Niazi S, Perlman AI, Halamka JD, Abu AM. Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review Health Policy and Technology. 2023; 12(4). Munipalli B, Ma Y, Li Z, Ganesh R, Knight D, Logvinov II, Paul SN, Delaney TR, Abu Dabrh AM. Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital. J Investig Med. 2023 Dec; 71 (8):896-906 Epub 2023 Aug 12 View PubMed Venable E, Knight DRT, Thoreson EK, Baudhuin LM. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder. Am J Med Genet C Semin Med Genet. 2023 Jun; 193(2):147-159. Epub 2023 Mar 09. View PubMed Knight DRT, Bruno KA, Gehin JM, Lothman KA, Leschitz J, Lazo AL, Mejia L, Motherwell LS, Seymour-Sonnier AM, Dawson NL, Fairweather D. The Impact of a Group Telemedicine Program for Chronic Disease: A Retrospective Cohort Survey Study on Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder. Telemed J E Health. 2023 Feb; 29 (2):261-269 Epub 2022 June 07 View PubMed Rivera FA, Munipalli B, Allman ME, Hodge DO, Wieczorek MA, Wang B, Abril A, Perlman A, Knight D, Bruce B. A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Front Med (Lausanne). 2023; 10:1301944 Epub 2024 Jan 15 View PubMed Fairweather D, Bruno KA, Darakjian AA, Bruce BK, Gehin JM, Kotha A, Jain A, Peng Z, Hodge DO, Rozen TD, Munipalli B, Rivera FA, Malavet PA, Knight DRT. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Front Med (Lausanne). 2023; 10:1096180 Epub 2023 Apr 25 View PubMed Knight DRT, Munipalli B, Logvinov II, Halkar MG, Mitri G, Dabrh AMA, Hines SL. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19. Am J Med Sci. 2022 Apr; 363 (4):295-304 Epub 2022 Jan 10 View PubMed Knight DRT, Confiado SM, Bruno KA, Fairweather D, Seymour-Sonnier AM, Jain A, Gehin JM, Whelan ER, Culberson JH, Munipalli B, Dawson NL, Rozen TD, Wick JJ, Kotha A. Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned. SN Compr Clin Med. 2022; 4 (1):138 Epub 2022 July 05 View PubMed Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. 2022; 4 (1):90 Epub 2022 Apr 04 View PubMed Munipalli B, Allman ME, Chauhan M, Niazi SK, Rivera F, Abril A, Wang B, Wieczorek MA, Hodge DO, Knight D, Perlman A, Abu Dabrh AM, Dudenkov D, Bruce BK. Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221120738. View PubMed Munipalli B, Knight D, Logvinov I, Abu Dabrh AM. Prevalence, Demographics, and Risk of Severe Acute COVID-19. Cureus. 2021 Oct; 13 (10):e18851 Epub 2021 Oct 18 View PubMed Knight D, Dudenkov DV, Cheshire WP. Religion in the US during the time of a Pandemic: A Medical Perspective. J Relig Health. 2021 Oct; 60 (5):3177-3192 Epub 2021 Aug 02 View PubMed Knight D. COVID-19 Pandemic Origins: Bioweapons and the History of Laboratory Leaks. South Med J. 2021 Aug; 114 (8):465-467 View PubMed Malouff TD, TerKonda SP, Knight D, Abu Dabrh AM, Perlman AI, Munipalli B, Dudenkov DV, Heckman MG, White LJ, Wert KM, Pascual JM, Rivera FA, Shoaei MM, Leak MA, Harrell AC, Trifiletti DM, Buskirk SJ. Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug; 5 (4):771-782 Epub 2021 July 01 View PubMed Knight D, Downes K, Munipalli B, Halkar MG, Logvinov II, Speicher LL, Hines SL. Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting. SN Compr Clin Med. 2021; 3 (1):247-254 Epub 2021 Jan 14 View PubMed Jethwa T, Ton A, Paredes Molina CS, Speicher L, Walsh K, Knight D, Davlantes T, Francis D. Establishing Mayo Clinic's Coronavirus Disease 2019 Virtual Clinic: A Preliminary Communication. Telemed J E Health. 2020 Nov; 26 (11):1419-1423 Epub 2020 June 09 View PubMed Woodruff A, Walsh KL, Knight D, Irizarry-Alvarado JM. COVID-19 infection: Strategies on when to discontinue isolation, a retrospective study. Am J Infect Control. 2020 Sep; 48 (9):1032-1036 Epub 2020 July 04 View PubMed Knight D, Irizarry-Alvarado J. SARS-CoV-2 serological testing changes disease management in a PCR-negative patient. BMJ Case Rep. 2020 Aug 11; 13 (8) View PubMed PST-20477204 主页 出版物